Floatz logo

Therapeutic Asset Ratings

128 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
FLUOROURACILUM
Colon Cancer
AkesoP4BB (70)
Calcium folinate pentahydrate
Colon Cancer
AkesoP3BB (69)
Eloxatin
Colon Cancer
Sun Yat-sen UniversityP3BB (69)
Irinotecan
Colon Cancer
SCRI Development Innovations, LLCP3BB (68)
MACROGOLS
Colon Cancer
University Medical Center Ho Chi Minh City (UMC)P4BB (66)
PANITUMUMAB
Colon Cancer
IFOM ETS - The AIRC Institute of Molecular OncologyP3B (63)
Cetuximab
Colon Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP3B (62)
DEXAMETHASONE
Colon Cancer
Institute of Oncology LjubljanaP4B (61)
LIDOCAINE
Colon Cancer
Institute of Oncology LjubljanaP4B (61)
NEPENTHE
Colon Cancer
Tel Aviv UniversityP4B (61)
Cyclophosphamide
Colon Cancer
Essen BiotechP2B (61)
Capecitabine
Colon Cancer
Sun Yat-sen UniversityP3B (60)
Epirubicin
Colon Cancer
Sun Yat-sen UniversityP3B (60)
Nivolumab
Colon Cancer
IFOM ETS - The AIRC Institute of Molecular OncologyP3B (60)
Iodixanol
Colon Cancer
Brian Henick, MDP2B (59)
MITOMYCIN C
Colon Cancer
City of Hope Medical CenterP4B (58)
Palbociclib
Colon Cancer
Lebanese UniversityP2B (58)
Pembrolizumab
Colon Cancer
Ismail GögenurP2B (58)
Atezolizumab
Colon Cancer
Baylor College of MedicineP3B (57)
Dfn-15
Colon Cancer
University of CopenhagenP3B (57)
Docetaxel
Colon Cancer
Sun Yat-sen UniversityP3B (57)
Acetylsalicylic Acid
Colon Cancer
M.D. Anderson Cancer CenterP3B (56)
Icosapent Ethyl
Colon Cancer
Massachusetts General HospitalP3B (56)
Iparomlimab
Colon Cancer
Fujian Medical UniversityP3B (56)
Ipilimumab
Colon Cancer
IFOM ETS - The AIRC Institute of Molecular OncologyP3B (56)
Showing 1 to 25 of 128 assets
PreviousPage 1 of 6Next